Northern Trust Company of Connecticut’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Northern Trust Company of Connecticut’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$5.42M	Sell	212,208 -44,308	-17%	-$1.37M	0.03%	664
2013 Q3	$7.67M	Sell	256,516 -14,543	-5%	-$404K	0.05%	531
2013 Q2	$7.79M	Buy	+271,059	New	+$7.47M	0.05%	512

Other funds holding BRLI

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

CS McKee Pittsburgh, Pennsylvania $1.09B AUM 31.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Company of Connecticut's BRLI Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its BIO-REFERENCE LABS INC-NEW- (BRLI) stake by 17% in Q4 2013, selling an estimated $1.37M and leaving 212,208 shares worth $5.42M. The position accounts for 0.03% of the portfolio, ranked #664.

Northern Trust Company of Connecticut first reported a position in BRLI in Q2 2013 and has held it in 3 quarters since. The position peaked at $7.79M in Q2 2013. 175 funds tracked by Wall St. Rank hold BRLI as of Q4 2013.

Northern Trust Company of Connecticut held 212,208 shares of BIO-REFERENCE LABS INC-NEW- worth $5.42M as of Q4 2013.
Northern Trust Company of Connecticut sold 44,308 BIO-REFERENCE LABS INC-NEW- shares in Q4 2013, an estimated $1.37M.
BIO-REFERENCE LABS INC-NEW- made up 0.03% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #664 holding.
Northern Trust Company of Connecticut first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and has held it in 3 quarters since.
Northern Trust Company of Connecticut's BIO-REFERENCE LABS INC-NEW- position peaked at $7.79M in Q2 2013.
175 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.